Home › NDC Lookup › RxCUI directory › RxCUI 977990

Halobetasol propionate 0.5 MG/ML Topical Cream — RxCUI 977990

RxNorm drug concept · Semantic clinical drug
RxCUI 977990 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI977990
Official nameHalobetasol propionate 0.5 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashalobetasol propionate 0.05 % Topical Cream
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)32,944 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Halobetasol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Halobetasol topical is used to treat inflammatory skin conditions — conditions that cause redness, swelling, and itching. The ointment form is used broadly for skin conditions that...
  • You should use halobetasol topical for no longer than two consecutive weeks, and no more than 50 grams total per week. It's a very potent steroid, and using it longer or in larger...
  • Yes — avoid applying halobetasol to your face, groin, or underarms. These areas have thinner skin and absorb much more of the medication, increasing your risk of side effects. Also...
  • Are there places I should not apply this?
📖 Read our full Halobetasol Topical guide →

🕸️ Concept Web — How Halobetasol propionate 0.5 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Halobetasol propionate 0.5 MG/ML Topical Cream RxCUI 977990

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Halobetasol 41208
    • Halobetasol propionate 45318
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Halobetasol Topical Cream 378637
    • Halobetasol propionate Topical Cream 2648234
    • Halobetasol Topical Product 1158362
    • Halobetasol propionate Topical Product 2659417
    • Topical Cream 316982
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Halobetasol propionate 0.5 MG/ML 977989

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Halobetasol propionate 0.5 MG/ML SCDC · 977989
  • Halobetasol Topical Cream SCDF · 378637
  • Halobetasol propionate Topical Cream SCDFP · 2648234
  • Halobetasol Topical Product SCDG · 1158362
  • Halobetasol propionate Topical Product SCDGP · 2659417

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 977990 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00713-0640-15 15 g in 1 TUBE (0713-0640-15) Halobetasol Propionate Cosette Pharmaceuticals, Inc. 2007-07-16
00713-0640-86 50 g in 1 TUBE (0713-0640-86) Halobetasol Propionate Cosette Pharmaceuticals, Inc. 2007-07-16
45802-0129-32 1 TUBE in 1 CARTON (45802-129-32) / 50 g in 1 TUBE Halobetasol Propionate Padagis Israel Pharmaceuticals Ltd 2008-08-04
45802-0129-35 1 TUBE in 1 CARTON (45802-129-35) / 15 g in 1 TUBE Halobetasol Propionate Padagis Israel Pharmaceuticals Ltd 2008-08-04
72162-2331-02 1 TUBE in 1 CARTON (72162-2331-2) / 50 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2024-06-18
Observed labelers: Cosette Pharmaceuticals, Inc. (2) · Padagis Israel Pharmaceuticals Ltd (2) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.5815
Range $0.4330–$0.7301 · middle 50% $0.4330–$0.7301 · 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.